First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction

Placenta

Volumn 32, Issue 4, 2011, Pages 333-338

  Odibo, A O ^a   Zhong, Y ^a,b   Longtine, M ^a   Tuuli, M ^a   Odibo, L ^a   Cahill, A G ^a   Macoes, G A ^a   Nelson, D M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

4 D placenta vascularization; Fetal growth restriction; Placental morphometry; Preeclampsia; Serum analytes; Uterine artery Doppler

Indexed keywords

ACTIVIN A; ADAM PROTEIN; CHORIONIC GONADOTROPIN; EOSIN; FORMALDEHYDE; HEMATOXYLIN; PLACENTA PROTEIN; PLACENTA PROTEIN 13; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FETUS GROWTH; FETUS WEIGHT; FIRST TRIMESTER PREGNANCY; FLUOROMETER; GESTATIONAL AGE; HISTOGRAM; HUMAN; MATERNAL HYPERTENSION; MORPHOMETRICS; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; UMBILICAL ARTERY; UTERINE ARTERY;

ADAM PROTEINS; ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FETAL GROWTH RETARDATION; GALECTINS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MEMBRANE PROTEINS; PLACENTA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 79952735936     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2011.01.016     Document Type: Article

References (31)

1. Poon LCY, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-8.
2. Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol 2009 Oct;201 (4):412.e1-6.
3. Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. Predicting the risk of pre-eclampsia by combining maternal characteristics and first-trimester serum analytes. Prenat Diagn 2010;30:1138-42.
4. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000;107:1265-70.
5. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. Prediction of preeclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol 2006;27:658-63. 29.
6. Spencer K, Cowans NJ, Stamatopoulou A. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Prenat Diagn 2008 Mar;28(3):212-6. (Pubitemid 351427940)
7. Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factors system. Prenat Diagn 2007;27:264-71. (Pubitemid 46450586)
8. Gonen R, Shahar R, Grimpel YI, Chefetz I, Sammar M, Meiri H, et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. BJOG 2008 Nov;115(12):1465-72.
9. Romero R, Kusanovic JP, Than NG, Erez O, Gotsch F, Espinoza J, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 2008 Aug;199(2):122.e1-122.e11.
10. Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007 Jul;197(1):35.e1-7.
11. Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynecol 2008;112(5):1082-90.
12. Hafner E, Metzenbauer M, Stümpflen I, Waldhör T, Philipp K. First trimester placental and myometrial blood perfusion measured by 3D power Doppler in normal and unfavourable outcome pregnancies. Placenta 2010 Sep;31 (9):756-63.
13. Dugoff L, Lynch AM, Cioffi-Ragan D, Hobbins JC, Schultz LK, Malone FD, et al. First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction. Am J Obstet Gynecol 2005 Sep;193(3 Pt 2):1208-12. (Pubitemid 41285521)
14. Hafner E, Metzenbauer M, Höfinger D, Stonek F, Schuchter K, Waldhör T, et al. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population. Ultrasound Obstet Gynecol 2006 Jun;27(6):652-7. (Pubitemid 43967368)
15. Kuzmina IY, Hubina-Vakulik GI, Burton GJ. Placental morphometry and Doppler flow velocimetry in cases of chronic human fetal hypoxia. Eur J Obstet Gynecol Reprod Biol 2005 Jun 1;120(2):139-45. (Pubitemid 40745316)
16. Noguchi J, Hata K, Tanaka H, Hata T. Placental vascular sonobiopsy using three-dimensional power Doppler ultrasound in normal and growth restricted fetuses. Placenta 2009;30:391-7.
17. Alcazar JL. Three-dimensional power Doppler derived vascular indices: what are we measuring and how are we doing it? Ultrasound Obstet Gynecol 2008;32:485-7.
18. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. In: ACOG practice bulletin, vol. 33. Washington, DC: The College; 2002.
19. Report of the National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
20. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan MA. United States national reference for fetal growth. Obstet Gynecol 1996;87:163-71.
21. Acharya G, Wilsgaard T, Berntsen GK, Maltau JM, Kiserud T. Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol 2005 Mar;192(3):937-44. (Pubitemid 40311293)
22. Mayhew TM. Stereology and the placenta: where's the point? A review. Placenta 2006 Apr;27(Suppl. A):S17-25 [Epub 2006 Jan 5].
23. Mayhew TM. Taking tissue samples from the placenta: an illustration of principles and strategies. Placenta 2008;29:1-14.
24. Mayhew TM. A stereological perspective on placental morphology in normal and complicated pregnancies. J Anat 2009 Jul;215(1):77-90 [Epub 2008 Jan 2].
25. Wyatt SM, Kraus FT, Roh CR, Elchalal U, Nelson DM, Sadovsky Y. The correlation between sampling site and gene expression in the term human placenta. Placenta 2005;26:372-9. (Pubitemid 40567914)
26. Mayhew T, Ohadike C, Baker P, Crocker I, Johnson I, Mitchell C, et al. P17 Quantitative analysis of placental microstructure in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. J Anat 2002 Nov;201(5):431.
27. Muhlfeld C, Nyengaard JR, Mayhew TM. A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovasc Pathol 2010;19:65-82.
28. Hitschold T, Weiss E, Beck T, Hünterfering H, Berle P. Low target birth weight or growth retardation? Umbilical Doppler flow velocity waveforms and histometric analysis of fetoplacental vascular tree. Am J Obstet Gynecol 1993 Apr;168(4):1260-4. (Pubitemid 23122177)
29. Proctor LK, Toal M, Keating S, Chitayat D, Okun N, Windrim RC, et al. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2009 Sep;34(3):274-82.
30. Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol 2010 Jun;35(6):662-70.
31. Huster KM, Haas K, Schoenborn J, McVean D, Odibo AO. Reproducibility of placental volume and vasculature indices obtained by 3-dimensional power Doppler sonography. J Ultrasound Med 2010 Jun;29(6):911-6.